Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission [Phase 3]
A Phase 3 clinical trial comparing stem cell transplantation to standard chemotherapy in patients with acute lymphoblastic leukemia in first…
-
FDA approval · 2023-06-15FDA Approved: CYTARABINE — Supplemental Application (Meitheal Pharmaceuticals Inc.)
FDA approved a supplemental application for Cytarabine from Meitheal Pharmaceuticals Inc., completing a modification to the existing Cytarab…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Effects of Malleo-Lok Stiffness on Lower Limb Mechanics [NA]
Clinical trial update on the effects of Malleo-Lok stiffness on lower limb mechanics; study completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Engineering Evaluation of the Helix Ventilator [NA]
This update reports the completion and posting of results for Philips Respironics' engineering evaluation of the Helix Ventilator, with cond…
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I [Phase 1, Phase 2]
This update covers the Total Therapy approach for infants with acute lymphoblastic leukemia in Phase 1/Phase 2, sponsored by St. Jude Childr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-24Clinical Trial Update: Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children [Phase 2]
Phase 2 trial evaluating imatinib added to chemotherapy for Philadelphia chromosome–positive acute lymphoblastic leukemia in children has co…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Low Dose Daunorubicin in Pediatric Relapsed/Refractory Acute Leukemia [Phase 2]
Phase 2 clinical trial evaluating low-dose daunorubicin in pediatric relapsed/refractory acute leukemia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL [Phase 2]
Phase 2 clinical trial update exploring a residual disease-driven strategy for CARCIK (CD19) in adults and pediatric patients with B-cell pr…
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients [Phase 4]
Phase 4 trial update on intranasal ketamine for anxiolysis in pediatric emergency department patients; study terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT [Phase 2]
A Phase 2 clinical trial update examining venetoclax plus azacytidine with a modified Busulfan/cyclophosphamide (BUCY) conditioning regimen …
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 study evaluating intensity-modulated radiation therapy with etoposide and cyclophosphamide followed by donor stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy for treating children with acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy in children with newly diagnosed acute lymphoblastic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia [Phase 2]
Phase 2 trial evaluating Clofarabine plus Melphalan as a conditioning regimen before donor stem cell transplantation for patients with myelo…
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL) [NA]
A completed clinical trial studying the impact of diet and exercise on patients with B precursor acute lymphoblastic leukemia (ALL).
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children [Phase 2]
Phase 2 trial update evaluating liposomal cytarabine for central nervous system resistant or relapsed acute lymphoblastic leukemia in childr…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial final update evaluating blinatumomab in adult patients with minimal residual disease in B-precursor acute lymphoblast…
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99) [Phase 4]
Phase 4 clinical trial update for adult acute lymphocytic leukemia conducted in Germany; study completed.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial update for TC-110 T cells in adults with relapsed or refractory non-Hodgkin lymphoma or acute lymphoblastic leukemia (comple…
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia [Phase 1, Phase 2]
An early-phase pediatric and young adult trial evaluating CD19-directed CAR-T cell therapy for relapsed/refractory CD19+ acute leukemia has …
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant [Phase 2, Phase 3]
A Phase 2/3 clinical trial comparing thymoglobulin to alemtuzumab in patients undergoing allogeneic stem cell transplantation has been compl…
-
FDA approval · 2023-02-08FDA Approved: DASATINIB — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Dasatinib submitted by Prasco Laboratories. The action approves an additional submission under N…
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 trial of ProTmune for allogeneic hematopoietic cell transplantation in adults with hematologic malignancies completed; results pos…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. [Phase 2]
Phase 2 trial update evaluating a conditioning regimen (busulfan, fludarabine, etoposide) for hematopoietic stem cell transplantation in chi…
-
FDA approval · 2023-01-31FDA Approved: IMATINIB MESYLATE — Supplemental Application (BluePoint Laboratories)
FDA approves a supplemental application for Imatinib Mesylate from BluePoint Laboratories under an ANDA, confirming approval of a generic pr…